文献库搜索 | GeneLibs

Liu(L),Zhang(R),Xu(R),Chen(B),Lei(Y),Li(W) Front Oncol None

...TP53 as an independent risk factor for fast growth. This study found risk factors associated with fast-growing lung canc...

Lu(C),Matt(GY),Paul(R),Wang(J),Sioson(E),G... Blood 2026-07-23

...TP53 alteration landscape. ASHOP is an open-access resource to inform genomic and transcriptomic data interpretation for...

Jhaveri(K),Eli(LD),Hurvitz(SA),Brufsky(A),... Clin Cancer Res 2026-04-06

...TP53) mutations. The most common treatment-emergent adverse events were diarrhea, nausea, and constipation. N+T in patie...

Guo(X),Yang(L),Zhong(J),Wu(B),Yang(C),Wu(J... Exp Cell Res 2026-06-01

...TP53) in thyroid cells. These findings uncover that the PA-dependent IGF-I/MET/TP53/KLLN signaling axis contributes to i...

Wang(W),Liu(X),Liu(H),Abolhassani(H),Yan(H... Signal Transduct Target The... 2026-04-06

The tumor suppressor gene TP53 is the most frequently mutated gene in human cancers and has been a popular area of resea...

Enriquez-Vera(D),Li(J),Nakazaki-Aza(J),Moc... Virol J 2026-04-06

...TP53 (27%). Mutation burden correlated significantly with proviral load (r = 0.34, p = 0.003), and longitudinal analysis...

Gan(J),Cong(Y),Li(L),Ma(F),Yang(X),Deng(Y)... Assay Drug Dev Technol 2026-07-00

...TP53, EGFR, STAT3, AKT1, and IL-6 were the hub targets. TND significantly modulates inflammatory biological processes an...

Mendoza(RP),Smithgall(MC),Chen(X),Liu-Jari... Int J Gynecol Pathol 2026-07-01

...TP53 mutations ( P =0.013), while all endometrial tumors with PTEN alterations were negative for FOLR1 ( P =0.037). Over...

Li(L),Li(B),Hao(Y),Pang(B),Li(P),Li(C),Tan... Adv Sci (Weinh) 2026-07-00

...TP53 co-mutant tumors. AUTACE targets tumors via TP53-specific TCRs, elicits antitumor CD8+ T-cell responses through sur...

Nakra(G),Sharma(A),Mohamedali(R),Gedela(S)... Int J Surg Pathol 2026-09-00

...TP53 (exon 6; c.659A>G; p.Y220C; 61.50% VAF). Copy-number analysis showed ERBB2 amplification and gains in CDKN2A and CD...